U.S. Markets closed

GlaxoSmithKline, Ingredion Favored: Kramer Capital CIO

Oct.03 -- Hilary Kramer, chief investment officer at Kramer Capital Research, talks about U.S. stocks and corporate earnings. She speaks with Shery Ahn and Paul Allen on "Bloomberg Daybreak: Australia."